StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.12−0.06 (-1.89%)

Close on Nov 18, 2026Market cap $777.47MP/E –Yield –

Ardelyx shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Ardelyx's shares outstanding was 248M at Jun 30, 2026. For fiscal 2025 it was 241M, up 2.5% from the year before. Over ten years it grew 26.5% a year on average. The highest annual figure on record is 241M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025241M+2.5%
FY2024Dec 31, 2024235M+7.3%
FY2023Dec 31, 2023219M+38.2%
FY2022Dec 31, 2022159M+52.3%
FY2021Dec 31, 2021104M+16.3%
FY2020Dec 31, 202090M+38.9%
FY2019Dec 31, 201964M+14.7%
FY2018Dec 31, 201856M+18.5%
FY2017Dec 31, 201747M+18.2%
FY2016Dec 31, 201640M+75.2%
FY2015Dec 31, 201523M+123.4%
FY2014Dec 31, 201410M+808.6%
FY2013Dec 31, 20131M+30.5%
FY2012Dec 31, 20121M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026248M+3.4%
Q1 FY2026Mar 31, 2026246M+3.0%
Q4 FY2025Dec 31, 2025244M+2.6%
Q3 FY2025Sep 30, 2025242M+2.5%
Q2 FY2025Jun 30, 2025240M+2.3%
Q1 FY2025Mar 31, 2025239M+2.4%
Q4 FY2024Dec 31, 2024237M+2.1%
Q3 FY2024Sep 30, 2024236M+3.5%
Q2 FY2024Jun 30, 2024235M+9.1%
Q1 FY2024Mar 31, 2024233M+12.6%
Q4 FY2023Dec 31, 2023232M+20.5%
Q3 FY2023Sep 30, 2023228M+38.0%
Q2 FY2023Jun 30, 2023215M+47.7%
Q1 FY2023Mar 31, 2023207M+58.1%
Q4 FY2022Dec 31, 2022193M+67.1%
Q3 FY2022Sep 30, 2022165M+58.5%
Q2 FY2022Jun 30, 2022146M+45.5%
Q1 FY2022Mar 31, 2022131M+34.7%
Q4 FY2021Dec 31, 2021115M+26.8%
Q3 FY2021Sep 30, 2021104M+16.5%
Q2 FY2021Jun 30, 2021100M+12.3%
Q1 FY2021Mar 31, 202197M+9.3%
Q4 FY2020Dec 31, 202091M+30.2%
Q3 FY2020Sep 30, 202089M+42.2%
Q2 FY2020Jun 30, 202089M+42.2%
Q1 FY2020Mar 31, 202089M+42.1%
Q4 FY2019Dec 31, 201970M+12.2%
Q3 FY2019Sep 30, 201963M+1.2%
Q2 FY2019Jun 30, 201963M+18.6%
Q1 FY2019Mar 31, 201963M+31.5%
Q4 FY2018Dec 31, 201862M+31.0%
Q3 FY2018Sep 30, 201862M+30.8%
Q2 FY2018Jun 30, 201853M+11.4%
Q1 FY2018Mar 31, 201848M+0.5%
Q4 FY2017Dec 31, 201748M+0.4%
Q3 FY2017Sep 30, 201747M+5.6%
Q2 FY2017Jun 30, 201747M–
Q1 FY2017Mar 31, 201747M–
Q4 FY2016Dec 31, 201647M–
Q3 FY2016Sep 30, 201645M–

More Ardelyx figures

See a number that looks wrong?